Upington disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3408OMIM:191520M91.8
Who is this for?
Show terms as
3FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Upington disease, also known as Upington bone disease or perthes-like hip dysplasia, is an extremely rare skeletal disorder first described in a large Afrikaner family from Upington, South Africa. The condition primarily affects the skeletal system, particularly the hip joints, and is characterized by enchondroma-like lesions of the long bones and a bilateral hip disorder resembling Perthes disease (avascular necrosis of the femoral head). Affected individuals typically develop progressive hip joint abnormalities during childhood, which can lead to pain, limited range of motion, and difficulty walking. The disease manifests with bilateral flattening and fragmentation of the femoral heads, similar to Legg-Calvé-Perthes disease, but distinguished by its hereditary pattern and the presence of additional skeletal abnormalities including enchondroma-like cartilaginous lesions in the metaphyses of tubular bones. Radiographic findings may also include irregularities of the epiphyses and metaphyses of other long bones beyond the hips. The condition can lead to early-onset degenerative arthritis of the hip joints. There is no specific curative treatment for Upington disease. Management is primarily supportive and symptomatic, focusing on orthopedic interventions to preserve hip joint function, pain management, and physical therapy. In severe cases, surgical procedures including hip replacement may be necessary. Due to the extreme rarity of this condition, knowledge is largely based on the original family described in the medical literature, and further research is needed to fully characterize the natural history and optimal management strategies.

Also known as:

Clinical phenotype terms— hover any for plain English:

Arthralgia of the hipHP:0003365Flat capital femoral epiphysisHP:0003370Broad femoral neckHP:0006429Premature epimetaphyseal fusionHP:0010588EnchondromaHP:0030038
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

3 available

Urea 39.5% With 2% Salicylic Acid

UREA, SALICYLIC ACID· PureTek Corporation

Urea is useful for the treatment of damaged, ingrown and devitalized nails

Dermacure

UREA 41%· Oncora Pharma, LLC

Urea is useful for the treatment of damaged, ingrown and devitalized nails

Urea Cream 40 Percent

UREA· Method Pharmaceuticals, LLC

Urea is useful for the treatment of damaged, ingrown and devitalized nails

No actively recruiting trials found for Upington disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Upington disease community →

No specialists are currently listed for Upington disease.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Upington disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Upington diseaseForum →

No community posts yet. Be the first to share your experience with Upington disease.

Start the conversation →

Latest news about Upington disease

No recent news articles for Upington disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Upington disease

What is Upington disease?

Upington disease, also known as Upington bone disease or perthes-like hip dysplasia, is an extremely rare skeletal disorder first described in a large Afrikaner family from Upington, South Africa. The condition primarily affects the skeletal system, particularly the hip joints, and is characterized by enchondroma-like lesions of the long bones and a bilateral hip disorder resembling Perthes disease (avascular necrosis of the femoral head). Affected individuals typically develop progressive hip joint abnormalities during childhood, which can lead to pain, limited range of motion, and difficulty

How is Upington disease inherited?

Upington disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Upington disease typically begin?

Typical onset of Upington disease is childhood. Age of onset can vary across affected individuals.